The expression of MIR17HG protein as a potential therapeutic target in meningioma.

Clicks: 324
ID: 97006
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #23 of 82 articles by views in world neurosurgery

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
MIR17 host gene (MIR17HG) is a potential therapeutic target for some cancer types. The aim of this study was to assess MIR17HG protein levels in patients with meningioma which were not reported previously in the literature and comparing with normal meninges tissues.MIR17HG protein levels were measured in total of 46 samples including 25 meningioma tissues procured during surgery and 21 normal meninges tissues obtained within 4 hours of death during autopsy procedures. Each samples were stored at -80 °C until the evaluation of MIR17HG protein with sandwich-ELISA principle. Results were compared between the groups.MIR17HG protein levels were significantly higher in meningioma tissues when compared to controls and difference was statistically significant (p=0.012). Both WHO grade-I and grade-II meningiomas had higher MIR17HG protein levels compared to controls and differences were statistically significant (p=0.026 for grade-I, p=0.042 for grade-II). ROC analysis was performed to determine the cut-off of MIR17HG protein value in differentiating meningioma and control groups. At the cut-off value for MIR17HG protein of > 0.0998 ng/ml, the sensitivity was 73.91%, 71.43%, 77.78% and area under the curve were 0.756, 0.753, 0.761 for meningioma group, grade-I and grade-II subgroups respectively and specificity was 69.23% for each group.MIR17HG protein expression was found higher level in meningiomas than normal meninges tissues in our study. Considering the recurrency and irresectability for some meningiomas which require further treatment, MIR17HG may be a new target for treatment in meningiomas and our study will shed light on further studies.
Reference Key
evran2020theworld Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Evran, Sevket;Baran, Oguz;Kayhan, Ahmet;Katar, Salim;Akkaya, Enes;Cevik, Serdar;Kaya, Mustafa;Sonmez, Derya;Serin, Huriye;Kaynar, Mehmet Yasar;
Journal world neurosurgery
Year 2020
DOI
S1878-8750(20)30314-4
URL
Keywords
protein meningioma genetic mirna mir17hg mir17-92 cluster

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.